about
Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases.High expression of HLA-E in colorectal carcinoma is associated with a favorable prognosis.Decrease of survivin, p53 and Bcl-2 expression in chemorefractory colorectal liver metastases may be predictive of radiosensivity radiosensivity after radioembolization with yttrium-90 resin microspheresSurvival of hereditary non-polyposis colorectal cancer patients compared with sporadic colorectal cancer patients.Detection of ATM germline variants by the p53 mitotic centrosomal localization test in BRCA1/2-negative patients with early-onset breast cancer.Sexual dysfunction following surgery for rectal cancer - a clinical and neurophysiological study.Cell surface overexpression of galectin-3 and the presence of its ligand 90k in the blood plasma as determinants in colon neoplastic lesions.Detection of phosphorylated insulin receptor in colorectal adenoma and adenocarcinoma: implications for prognosis and clinical outcome.HLA-A, -B, -C expression in colon carcinoma mimics that of the normal colonic mucosa and is prognostically relevant.Prognostic value of soluble P-selectin levels in colorectal cancer.P53 and bcl-2 in colorectal cancer arising in patients under 40 years of age: distribution and prognostic relevance.Tumor Regression Grade After Neoadjuvant Chemoradiation and Surgery for Low Rectal Cancer Evaluated by Multiple Correspondence Analysis: Ten Years as Minimum Follow-up.Bolus vs. continuous hepatic arterial infusion of cisplatin plus intravenous 5-fluorouracil chemotherapy for unresectable colorectal metastasesA proposal of an updated classification for pelvic relapses of rectal cancer to guide surgical decision-makingElective colorectal cancer surgery at the oncologic hub of Lombardy inside a pandemic COVID-19 area
P50
Q34059726-4ED8A179-03A3-413D-B62D-6D39BBA0DA8DQ35560099-51877302-2E7C-489A-8E7E-1B7C441326F1Q36697911-C269AAE1-2496-4441-9EAB-D14D5CDEE6EFQ36919780-2632F214-C847-4A2E-9837-EBF8F4C00F8DQ37233477-E5E46C20-A544-405B-AF73-C0B12DDE8A94Q37379861-0AA6501E-53DD-4CF4-AAF7-443FC64726CDQ38341250-A6DE4241-AB81-43CA-A511-FA16E698848CQ38390595-A6BB5DFE-9080-4B23-A964-0C0EFEAD839AQ38434688-FAA3BEE6-3BEA-4467-A00C-AD343D8293DAQ47278554-ACC01FA2-7A2F-4221-B2E0-384888169131Q53322018-7B293FB4-12BC-435D-9C10-0FD6D29442F8Q53544032-980C839C-1AB0-4B5A-B876-7FB6E1EA1E90Q61900453-6D35063F-A1D9-4DD9-B389-589A4D5CD5ABQ95336646-703FD033-8477-4256-B0F9-B403E776002BQ96019700-DEE9EA18-CAAF-481F-A3D3-B150C0322D42
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Maurizio Cosimelli
@ast
Maurizio Cosimelli
@en
Maurizio Cosimelli
@es
Maurizio Cosimelli
@nl
type
label
Maurizio Cosimelli
@ast
Maurizio Cosimelli
@en
Maurizio Cosimelli
@es
Maurizio Cosimelli
@nl
prefLabel
Maurizio Cosimelli
@ast
Maurizio Cosimelli
@en
Maurizio Cosimelli
@es
Maurizio Cosimelli
@nl
P106
P1153
7005360536
P31
P496
0000-0002-3462-0449